Clinical Trial Update: A Study to Compare Forms of Nemtabrutinib (MK-1026) in Healthy Adult Participants (MK-1026-007) [Phase 1]

View source ↗

Summary

A Phase 1 study comparing different forms of nemtabrutinib (MK-1026) in healthy adult participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Nemtabrutinib (nemtabrutinib)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hematological Malignancy | Phase 1 | Status: COMPLETED